Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEZEPELUMAB-EKKO: 4,398 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
4,398
Total FAERS Reports
190 (4.3%)
Deaths Reported
798
Hospitalizations
4,398
As Primary/Secondary Suspect
116
Life-Threatening
40
Disabilities
Prescription
Status

FDA Application: 761224 ·

First Report: 20151110 · Latest Report: 20250925

What Are the Most Common TEZEPELUMAB-EKKO Side Effects?

#1 Most Reported
Asthma
630 reports (14.3%)
#2 Most Reported
Dyspnoea
382 reports (8.7%)
#3 Most Reported
Arthralgia
381 reports (8.7%)

All TEZEPELUMAB-EKKO Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Asthma 630 14.3% 8 241
Dyspnoea 382 8.7% 5 102
Arthralgia 381 8.7% 0 27
Drug ineffective 358 8.1% 2 107
Pneumonia 192 4.4% 8 97
Back pain 184 4.2% 0 14
Cough 182 4.1% 0 34
Rash 177 4.0% 0 13
Pain 148 3.4% 2 14
Product dose omission issue 146 3.3% 2 20
Headache 145 3.3% 1 20
Death 140 3.2% 133 4
Fatigue 140 3.2% 0 21
Dizziness 134 3.1% 0 17
Injection site pain 121 2.8% 0 11
Urticaria 114 2.6% 0 15
Device leakage 104 2.4% 0 7
Hypersensitivity 103 2.3% 0 11
Wheezing 103 2.3% 0 36
Pruritus 99 2.3% 0 8

Who Reports TEZEPELUMAB-EKKO Side Effects? Age & Gender Data

Gender: 74.5% female, 25.5% male. Average age: 56.9 years. Most reports from: US. View detailed demographics →

Is TEZEPELUMAB-EKKO Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 1 0 1
2016 1 0 1
2017 2 0 1
2018 2 0 1
2019 4 1 1
2020 3 0 1
2021 3 0 0
2022 258 15 46
2023 376 31 96
2024 384 20 102
2025 270 12 50

View full timeline →

What Is TEZEPELUMAB-EKKO Used For?

IndicationReports
Asthma 2,284
Product used for unknown indication 89
Chronic obstructive pulmonary disease 22
Single umbilical artery 19
Adverse drug reaction 13
Asthmatic crisis 9
Severe asthma with fungal sensitisation 9
Asthma-chronic obstructive pulmonary disease overlap syndrome 5
Hypersensitivity 5

TEZEPELUMAB-EKKO vs Alternatives: Which Is Safer?

TEZEPELUMAB-EKKO vs THALIDOMIDE TEZEPELUMAB-EKKO vs THALOMID TEZEPELUMAB-EKKO vs THEOPHYLLINE TEZEPELUMAB-EKKO vs THEOPHYLLINE ANHYDROUS TEZEPELUMAB-EKKO vs THIAMINE TEZEPELUMAB-EKKO vs THIOCOLCHICOSIDE TEZEPELUMAB-EKKO vs THIOGUANINE TEZEPELUMAB-EKKO vs THIOGUANINE ANHYDROUS TEZEPELUMAB-EKKO vs THIOPENTAL TEZEPELUMAB-EKKO vs THIORIDAZINE

Official FDA Label for TEZEPELUMAB-EKKO

Official prescribing information from the FDA-approved drug label.